{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
M K Proteins Ltd
M K Proteins Ltd is Rated Sell
M K Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 November 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 January 2026, providing investors with the latest insights into its performance and outlook.
M K Proteins Ltd Stock Falls to 52-Week Low of Rs.5.11
M K Proteins Ltd, a player in the edible oil sector, recorded a fresh 52-week low of Rs.5.11 today, marking a significant decline in its stock price amid a broader market downturn and persistent underperformance relative to its sector and benchmark indices.
M K Proteins Ltd is Rated Sell by MarketsMOJO
M K Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 January 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
M K Proteins Ltd is Rated Sell by MarketsMOJO
M K Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
M K Proteins Ltd is Rated Sell by MarketsMOJO
M K Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 November 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 December 2025, providing investors with an up-to-date view of the company's performance and outlook.
M K Proteins Sees Revision in Market Evaluation Amid Mixed Financial Signals
M K Proteins, a microcap player in the edible oil sector, has experienced a revision in its market evaluation metrics, reflecting nuanced shifts across key financial and technical parameters. This adjustment comes amid ongoing challenges in the company’s financial performance and stock price trends, underscoring the complexities faced by investors in this segment.
How has been the historical performance of M K Proteins?
M K Proteins' historical performance shows fluctuating revenue, with net sales increasing to 267.71 Cr in March 2025 from 245.57 Cr in March 2024, but declining from 314.86 Cr in March 2023. Profitability decreased, with operating profit falling to 12.43 Cr and cash flow showing a negative trend, indicating challenges in profitability and cash management despite some sales growth.
Is M K Proteins overvalued or undervalued?
As of November 19, 2025, M K Proteins is considered very attractive and undervalued, with a PE ratio of 28.91, an EV to EBITDA of 18.57, and a ROCE of 17.66%, making it a compelling investment opportunity despite a year-to-date return of -20.34%.
How has been the historical performance of M K Proteins?
M K Proteins has shown fluctuating financial performance, with net sales increasing to 267.71 Cr in March 2025 from 245.57 Cr in March 2024, but declining from 314.86 Cr in March 2023. Profitability has decreased, with profit after tax falling to 8.40 Cr in March 2025, and cash flow from operating activities turning negative at -16.00 Cr.
How has been the historical performance of M K Proteins?
M K Proteins has shown fluctuating financial performance, with net sales increasing to 267.71 Cr in Mar'25 from 245.57 Cr in Mar'24, but down from 314.86 Cr in Mar'23. Key metrics like operating profit and profit after tax have decreased, while total assets and liabilities rose, indicating a challenging operational environment.
M K Proteins Ltd Surges 1.50% Today, Marking Three Consecutive Days of Gains at 5.72%
M K Proteins Ltd, a microcap in the edible oil sector, is experiencing notable buying activity, marking three consecutive days of gains. Despite a recent uptick, the stock has declined over the past month and year, contrasting with the broader market's performance. The sector's volatility may be influencing investor interest.
M K Proteins Reports Strong Growth Amidst Shifting Market Sentiment in Edible Oils
M K Proteins, a microcap in the edible oil sector, has recently adjusted its evaluation amid a shift in market sentiment. The company reported impressive quarterly results, with net sales of Rs 114.95 crore and a profit after tax of Rs 3.51 crore, despite facing challenges over the past year.
How has been the historical performance of M K Proteins?
M K Proteins has shown fluctuating financial performance, with net sales increasing to 267.71 Cr in Mar'25 from 245.57 Cr in Mar'24, but declining from 314.86 Cr in Mar'23. Profit after tax decreased to 8.40 Cr in Mar'25, and cash flow from operating activities turned negative at -16.00 Cr, indicating challenges in cash generation.
Why is M K Proteins falling/rising?
As of 20-Oct, M K Proteins Ltd's stock price is declining at 6.63, down 3.77%, and is trading below all major moving averages, indicating a bearish trend. The stock has underperformed significantly year-to-date, with an 18.75% decline compared to the Sensex's increase, reflecting low investor confidence and sector challenges.
How has been the historical performance of M K Proteins?
M K Proteins has shown fluctuating financial performance, with net sales increasing to 267.71 Cr in March 2025 from 245.57 Cr in March 2024, but declining from 314.86 Cr in March 2023. Operating profit and profits before and after tax have decreased, while total assets and liabilities rose significantly.
Why is M K Proteins falling/rising?
As of 24-Sep, M K Proteins Ltd's stock price is at 7.10, down 6.58%, and has underperformed its sector significantly. Despite a strong ability to service debt, the stock has seen a year-to-date decline of 12.99% and a one-year return of -22.49%, indicating ongoing challenges.
M K Proteins Shows Mixed Technical Signals Amid Strong Sales Growth
M K Proteins, a microcap in the edible oil sector, has seen a recent adjustment in its evaluation, reflecting a shift in market sentiment. The company reported a significant increase in Q1 FY25-26 net sales, achieving Rs 114.95 crore, while managing debt effectively despite a year-long stock decline.
How has been the historical performance of M K Proteins?
M K Proteins has experienced fluctuating financial performance, with net sales declining from 314.86 Cr in Mar'23 to 267.71 Cr in Mar'25, and a decrease in profit after tax to 8.40 Cr in Mar'25 from 11.21 Cr in Mar'24. Key metrics such as operating profit and earnings per share also fell, indicating significant financial challenges.
Why is M K Proteins falling/rising?
As of 11-Sep, M K Proteins Ltd is experiencing a price increase to 7.06, with a 2.32% upward change. Despite recent gains, the stock has a year-to-date decline of 13.48% and has underperformed its sector and the broader market.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
